Phase I Study of Intratumoral Administration of HF10, Oncolytic Herpes Simplex Virus Type 1, in Patients with Advanced Unresectable Pancreatic Cancer
Phase 1
- Conditions
- Advanced Unresectable Pancreatic Cancer
- Registration Number
- JPRN-UMIN000010150
- Lead Sponsor
- agoya University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with: -Ascites. pleural infusion. -Infectious disease. -Any other cancer. -Brain metastasis. -hypersensitivity to live-virus vaccine. Pregnant or breast feeding patient.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety and tolerability
- Secondary Outcome Measures
Name Time Method anti-tumor activity Immune response Viral replication